Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias - Test2 - elhamkhani - TriplyDB

Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias

Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias

http://www.wikidata.org/entity/Q28252023

about

Short and tall stature: a new paradigm emerges Fibroblast growth factor signaling in skeletal development and disease A pathway to bone: signaling molecules and transcription factors involved in chondrocyte development and maturation Structural Mimicry of A-Loop Tyrosine Phosphorylation by a Pathogenic FGF Receptor 3 Mutation Integrative modelling of the influence of MAPK network on cancer cell fate decision A novel loss-of-function mutation in Npr2 clarifies primary role in female reproduction and reveals a potential therapy for acromesomelic dysplasia, Maroteaux type Unexpected Cartilage Phenotype in CD4-Cre-Conditional SOS-Deficient Mice Extracellular Signal-Regulated Kinase Signaling in CD4-Expressing Cells Inhibits Osteochondromas.Pathogenic Cysteine Removal Mutations in FGFR Extracellular Domains Stabilize Receptor Dimers and Perturb the TM Dimer Structure.Reading and language disorders: the importance of both quantity and quality.Recent research on the growth plate: Recent insights into the regulation of the growth plate The Fibroblast Growth Factor signaling pathway Canine chondrodysplasia caused by a truncating mutation in collagen-binding integrin alpha subunit 10.Mutant activated FGFR3 impairs endochondral bone growth by preventing SOX9 downregulation in differentiating chondrocytes FGFR3 Deficiency Causes Multiple Chondroma-like Lesions by Upregulating Hedgehog Signaling.Fibroblast growth factor signaling in myofibroblasts differs from lipofibroblasts during alveolar septation in mice.Bladder cancer: a simple model becomes complex.Paleodysmorphology and paleoteratology: Diagnosing and interpreting congenital conditions of the skeleton in anthropological contexts.The impact of polyphenols on chondrocyte growth and survival: a preliminary report Fibroblast growth factor family aberrations in cancers: clinical and molecular characteristics Molecular Analysis of a Case of Thanatophoric Dysplasia Reveals Two de novo FGFR3 Missense Mutations located in cis.Conditional Deletion of Fgfr3 in Chondrocytes leads to Osteoarthritis-like Defects in Temporomandibular Joint of Adult Mice.FGFR3/fibroblast growth factor receptor 3 inhibits autophagy through decreasing the ATG12-ATG5 conjugate, leading to the delay of cartilage development in achondroplasia The Hippo signal transduction network for exercise physiologists A Track Record on SHOX: From Basic Research to Complex Models and Therapy New evidence for positive selection helps explain the paternal age effect observed in achondroplasia Expression of FGFR3 and FGFR4 and clinical risk factors associated with progression-free survival in synovial sarcoma Expression of Potential Regulatory Genes in Abdominal Adipose Tissue of Broiler Chickens during Early Development Quinoxaline derivatives: a patent review (2006--present).Temporal lobe dysplasia: a characteristic sonographic finding in thanatophoric dysplasia.Therapeutic effect of CNP on renal osteodystrophy by antagonizing the FGF-23/MAPK pathway.Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancer.Genetics of Short Stature.Achondroplasia and Biliary Atresia: A Rare Association and Review of Literature.Familial seborrhoeic keratosis associated with multiple "pure reticulated acanthomas" and infundibulocystic basal cell carcinomas.Effect of the achondroplasia mutation on FGFR3 dimerization and FGFR3 structural response to fgf1 and fgf2: A quantitative FRET study in osmotically derived plasma membrane vesicles.Further Evidence of Contrasting Phenotypes Caused by Reciprocal Deletions and Duplications: Duplication of NSD1 Causes Growth Retardation and Microcephaly.Identification and in silico characterization of p.G380R substitution in FGFR3, associated with achondroplasia in a non-consanguineous Pakistani family.FGFR3 deficient mice have accelerated fracture repair.Height outcome of short children with hypochondroplasia after recombinant human growth hormone treatment: a meta-analysis.

P2860

Q26781983-D055A982-84F1-41E6-B6C8-EB507C4D418F Q26798215-31AF7D11-6077-490B-8568-3A2F08A7B673 Q26995910-51EBFB51-8B5F-486F-BC01-AE68E638CF0F Q27679792-2C13EE52-F23C-41A8-A746-1DC665E98348 Q28534949-680A381A-2B1A-43B7-82F8-10F2B9ECB32D Q30359787-C6C208AC-7985-449F-BBF8-01B4D109C4E8 Q30842692-DF47269B-382E-4845-932D-C528F9C125AF Q33619286-B3F54C01-E9A2-493A-84F4-1A4D6D57A7F9 Q33810258-17A61DE3-51C1-4836-AC33-CD5E5C465D3B Q33891684-4C2EFE7A-5BC3-4D89-A221-28E27A99471F Q34046963-EEF7FEB0-6152-43BD-B03D-25654E2F45E0 Q34467171-61F29AB4-AAAF-48F1-BBEB-79AEA4644825 Q35005820-87BBB238-2E9F-4707-9B3F-426C937050C4 Q35152836-4466F7FF-0C96-438B-8FF9-DA6FA0AE94CC Q35668685-F644AEAD-CF30-4E42-BB4B-43633407C45B Q36017774-EE7DC39E-4EE5-4AAB-87BD-10F05FCB1338 Q36108115-F23D8CC2-B80D-41F2-BD71-B52EBA37DF10 Q36111018-5F56695F-5390-438F-8039-AF192D17196C Q36127934-FE4FABC5-A048-4883-9F13-D7D5101B4913 Q36189141-54BEA7D1-CEB8-4065-AC37-3502B5057553 Q36741096-2246EFF2-9366-4CB5-8AEF-39CFAA5135D5 Q36760664-59DE0CFE-D956-4347-BAF4-0ED04E1EF3B3 Q36777218-69C1B51F-6A81-4EF2-BE66-986CC922F05E Q36902243-B7E783B1-8283-45C2-B336-765A8F8B7300 Q37147401-1D5B8FEE-6500-453E-A849-F1744C16E0DB Q37193908-C035D6A1-90CC-4592-A5CF-B1C7D8610A20 Q37379626-2813A5F7-E625-4395-A348-9AC777E95423 Q37557031-775E627C-DBD2-4137-9C50-E209C61DB4D4 Q38042737-04D15552-C038-448D-B954-14558F80F824 Q38192552-76D35890-D3C2-46A5-85E3-55B9FE84EF98 Q38605457-9A719CFE-E3A2-4769-96B0-C97752AA1460 Q39137839-CD51218D-BE2F-4547-AE61-80E6BEBC1BE4 Q39286284-22219BAF-8E46-4512-AD07-AD4FB9B36A54 Q39301388-63B76BB2-8E7C-4B01-8529-8DA0F1D08934 Q39382077-FF0EE0F1-DF6D-43CB-9F80-8E18FB51971A Q39867428-08A35992-BA86-435D-8D85-B32569B609E5 Q40106100-7C4D9B96-4729-438E-AD1F-E0684AC4E6E7 Q40954475-AA91A302-87C0-4E9D-A5B1-659DD6D0FC7B Q41035989-DBE84F64-4524-423F-8E78-145C679CEA76 Q41134373-EC8895DC-EAF9-452F-8B2D-FEEC43A306FC

P2860

Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias

http://www.wikidata.org/entity/Q28252023

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Sixteen years and counting: th ...... gnaling in skeletal dysplasias

@ast

Sixteen years and counting: th ...... gnaling in skeletal dysplasias

@en

Sixteen years and counting: th ...... gnaling in skeletal dysplasias

@nl

type

label

Sixteen years and counting: th ...... gnaling in skeletal dysplasias

@ast

Sixteen years and counting: th ...... gnaling in skeletal dysplasias

@en

Sixteen years and counting: th ...... gnaling in skeletal dysplasias

@nl

prefLabel

Sixteen years and counting: th ...... gnaling in skeletal dysplasias

@ast

Sixteen years and counting: th ...... gnaling in skeletal dysplasias

@en

Sixteen years and counting: th ...... gnaling in skeletal dysplasias

@nl

P1433

Q28252023-72749B23-ED94-4D08-BA17-B9684B1B6345

P1476

Q28252023-CF7292B9-31F5-48A8-8752-850D56137591

P2093

Q28252023-89007DA3-3E04-4A3B-8375-C506747DED38

Q28252023-A7445B0D-ACEC-463E-8A6F-0F512C880D2F

P2860

Q28252023-013EEE67-1394-478E-8388-89240498CC20

Q28252023-054D6DCF-CBF3-48DF-9E63-9F1F1D1EF201

Q28252023-06BE9DAD-3006-4364-B9E0-B4B649E38E7E

Q28252023-076BFDC6-027A-4D62-9BE6-EC416FE6E322

Q28252023-07EDAA5C-8D1A-4037-85CE-5ADF32C28FC1

Q28252023-09F419FD-70BC-4617-9FC8-63C513E032C6

Q28252023-0A49D5D2-AF8A-416F-9127-474538ECEDF0

Q28252023-0A9778D7-9E05-4CAB-BD60-CC3FEB1231FA

Q28252023-0E961E19-4B86-48F1-9133-2E3386F915FE

Q28252023-123359A0-6AD5-4079-AE30-07689ADF3041

P304

Q28252023-F6B0A405-0F9F-40CA-A75A-DC8ABBEE4731

P31

Q28252023-78AB1D3C-2962-474E-BA5D-DEE9D686E059

P3181

Q28252023-8EE8A805-4B57-4953-917C-EBDD9BC99642

P356

Q28252023-06E655F7-5778-4ED5-985F-E982A7795877

P407

Q28252023-78A91A00-C28A-4215-A626-DA6D95372F21

P433

Q28252023-AE31A651-60F1-493C-B1F9-74402DA5946B

P478

Q28252023-919FA65C-DB81-4F4B-A9B6-15BAFF609CA9

P50

Q28252023-68D3F05B-5F95-43A9-A450-A1F9DE2ED6B6

P577

Q28252023-7C2D3536-1481-49DB-B8EB-492E1AA83930

P5875

Q28252023-42A20FBA-2BD4-4FF5-85F8-A8E0DD247D2C

P698

Q28252023-928E9332-C23A-4DC5-9998-21CBE8AD4ED8

P932

Q28252023-66C8A9BF-8591-412C-BFFE-59C42FF4826D

P3181

P356

P1433

P1476

Sixteen years and counting: th ...... gnaling in skeletal dysplasias

@en

P2093

Silvie Foldynova-Trantirkova

http://www.w3.org/2001/XMLSchema#string

William R Wilcox

http://www.w3.org/2001/XMLSchema#string

P2860

Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4

Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, Stat activation, and phosphatidylinositol 3-kinase activation

Cell responses to FGFR3 signalling: growth, differentiation and apoptosis

Sustained phosphorylation of mutated FGFR3 is a crucial feature of genetic dwarfism and induces apoptosis in the ATDC5 chondrogenic cell line via PLCgamma-activated STAT1

Fibroblast growth factor receptor 3 is a negative regulator of bone growth

Clinical and genetic heterogeneity of hypochondroplasia

Binding of Shp2 tyrosine phosphatase to FRS2 is essential for fibroblast growth factor-induced PC12 cell differentiation

FRS2 alpha attenuates FGF receptor signaling by Grb2-mediated recruitment of the ubiquitin ligase Cbl.

Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux

Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization

P304

29-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2503609

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/HUMU.21636

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51763327

http://www.w3.org/2001/XMLSchema#string

P698

22045636

http://www.w3.org/2001/XMLSchema#string

P932

3240715

http://www.w3.org/2001/XMLSchema#string